×

Atara Biotherapeutics (Nasdaq: ATRA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO

ADVISORY, Oct. 15, 2014 (GLOBE NEWSWIRE) -- --

What:

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which will occur today, October 16, 2014.

In honor of the occasion, Dr. Isaac Ciechanover, President & Chief Executive Officer will ring the Opening Bell.

Where:

Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Thursday, October 16, 2014 – 9:15 a.m. to 9:30 a.m. ET

Atara Biotherapeutics Media Contact:

Tina Gullotta

(415) 287-2427

press@atarabio.com

Nasdaq MarketSite:

Christine Barna

(646) 441-5310

Christine.Barna@nasdaq.com

Feed Information:

Fiber Line (Encompass Waterfront): 4463


Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page:

http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at:

http://twitter.com/nasdaq

For exciting viral content and ceremony photos visit Tumblr Page:

http://nasdaq.tumblr.com/

Webcast:
A webcast of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Atara Biotherapeutics (Nasdaq:ATRA):

Atara Biotherapeutics, Inc. is a drug development company focusing on innovative therapies for patients with debilitating diseases. The company’s lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. For more information, please visit www.atarabio.com.

About Nasdaq:

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.

-NDAQA-

Source:The NASDAQ OMX Group, Inc.